The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1684 participants.

Also called NCT01665053

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,684 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01665053
Other papers using this trial's data
  • Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents Circulation. Cardiovascular interventions, 2019-09 DOI, PubMed 31451014
  • Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial Circulation. Cardiovascular interventions, 2015-04 DOI, PubMed 25855680

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Italy, Japan, Latvia, Netherlands, New Zealand, Poland, Singapore, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01665053. Randomized; single masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2014-09 (actual). Results posted on 2016-01-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Intervention (Device)
PROMUS Element Plus
Intervention (Device)
SYNERGY
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01665053
Content hash
a64b1b2f9cdef952d282f0557dbccf47dc051da5a6aee6171e43e7823084fcc1